Stock Market & Financial Investment News

News Breaks February 27, 2013 13:43 EDT GSK, SRPT Duchenne muscular dystrophy patients hospitalized, TheStreet says Duchenne muscular dystrophy patients treated with drisapersen, GlaxoSmithKline's (GSK) experimental drug, have been hospitalized, according to a report by TheStreet that cites a Glaxo scientist speaking in Rome last Sunday. The report notes that Sarepta Therapeutics (SRPT) is meeting with the FDA this quarter to discuss the possibility of an accelerated approval filing for its Duchenne muscular dystrophy drug eteplirsen. Reference Link News For GSK;SRPT From The Last 14 Days Check below for free stories on GSK;SRPT the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. June 17, 2013 12:20 EDT SRPT Options with increasing implied volatility: WLT LNCO SRPT LINE Subscribe for More Information June 14, 2013 11:23 EDT SRPT Options with increasing implied volatility: TWO SRPT LNCO LINE DVA 06:15 EDT SRPT Leerink remains cautious on accelerated approval for Sarepta Subscribe for More Information June 12, 2013 19:54 EDT GSK GlaxoSmithKline investigates bribe claims in China, WSJ says Subscribe for More Information 07:16 EDT GSK GlaxoSmithKline fires head of R&D in China, WSJ says GlaxoSmithKline has fired it's head of R&D in China after finding that he had incorporated "misinterpreted" data in a paper he helped write for a journal, Nature Medicine, according to The Wall Street Journal, citing the company. Reference Link June 6, 2013 15:59 EDT GSK FDA votes for modified restrictions on GSK's Avandia, Reuters says Subscribe for More Information 15:42 EDT GSK FDA panel revote reaffirms modified restrictions for GSK's Avandia, Reuters says 15:26 EDT GSK FDA advisers say Glaxo Avandia vote may have been inaccurate, Bloomberg says Advisers plan to take a break to assess problem with vote tally and plan to re-vote on GSK's Avandia after break, Bloomberg says. 15:20 EDT GSK FDA panel votes to modify market restrictions for Avandia, Reuters says Subscribe for More Information June 5, 2013 13:29 EDT SRPT Options with decreasing implied volatility: INFI SRPT GES SUPN CPRT Subscribe for More Information 07:45 EDT GSK FDA to host a joint committee meeting Joint Meeting of the Endocrinilogic & Metabolic Drugs Advisory Committee and the Drug Safety & Risk Management Advisory Committee where the discussion on both days will be on GlaxoSmithKline's New Drug Application (NDA) 21071 for AVANDIA (Rosiglitazone Maleate) tablets is being held in FDA Offices in Silver Spring, Maryland on June 5-6 beginning at 8 am. Webcast Link June 4, 2013 07:06 EDT GSK Response Genetics achieves milestone payments totaling $1M from GlaxoSmithKline Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.